Cytokines Involved in Itch and Atopic Dermatitis: A Comprehensive List

This article provides a comprehensive list of cytokines that are involved in itch and Atopic Dermatitis. These cytokines play crucial roles in promoting itch, inflammation, and skin barrier dysfunction, contributing to the complex pathogenesis of this chronic skin condition.

1. Interleukin-31 (IL-31): IL-31 is a key cytokine involved in itch signaling. It is known to be elevated in Atopic Dermatitis patients and has been shown to directly induce itch sensations.

2. Interleukin-4 (IL-4): IL-4 is an important cytokine involved in the pathogenesis of Atopic Dermatitis. It plays a role in promoting itch and inflammation in the skin.

3. Interleukin-13 (IL-13): IL-13 is closely related to IL-4 and is also involved in the development of Atopic Dermatitis. It has been shown to induce itch and contribute to skin barrier dysfunction.

4. Tumor Necrosis Factor-alpha (TNF-α): TNF-α is a pro-inflammatory cytokine that is elevated in Atopic Dermatitis. It is known to contribute to itch and skin inflammation.

5. Interleukin-17 (IL-17): IL-17 is a cytokine produced by Th17 cells and is involved in various inflammatory conditions, including Atopic Dermatitis. It has been implicated in itch signaling and skin barrier disruption.

6. Interleukin-22 (IL-22): IL-22 is produced by Th22 cells and is elevated in Atopic Dermatitis. It has been shown to induce itch and contribute to skin inflammation.

7. Interleukin-23 (IL-23): IL-23 is involved in the differentiation and maintenance of Th17 cells. It has been found to be elevated in Atopic Dermatitis and may contribute to itch and inflammation.

8. Interferon-gamma (IFN-γ): IFN-γ is a cytokine produced by Th1 cells and has been implicated in the pathogenesis of Atopic Dermatitis. It can contribute to itch and skin barrier dysfunction.

It is important to note that this list is not exhaustive, and there may be other cytokines and inflammatory mediators involved in itch and Atopic Dermatitis. Ongoing research continues to unveil the complex interplay of these factors in the development and progression of this condition.